• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Jan. 2

Lupin Ltd on Tuesday said that it has received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Setraline Hydrochloride tablets in 25mg, 50mg and 100 mg. This is the company's 18th ANDA approval till date.

Setraline Hydrochloride tablet is used for the treatment of depressive disorders and will be the AB-generic equivalent of Pfizer's ZOLOFT tablets. The company plans on launching the generic on final approval, which is expected by February 2007. Shares of the company fell 0.20 per cent to close at Rs 610.85 on BSE.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Ranbaxy gets US FDA approval for hypertension drug

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line